April 13, 2014

Licensing Agreement to bring-in easy access to Dolutegravir (DTG).

          The License agreement between the Medicines Patent Pool (MPP) and ViiV Healthcare over a drug Dolutegravir (DTG) has brought new hope in the field of medicine. This New Drug Application (NDA) follows the approval of dolutegravir by the US Food and Drug Administration (FDA) in August 2013 under the brand name …

Licensing Agreement to bring-in easy access to Dolutegravir (DTG). Read More »

Patent suit against Biocon- Keeping Galvus in check…

The most famous drug for diabetes, Galvus also known as Vildagliptin is under patent litigation. Swiss drug maker Novartis has filed an infringement proceeding against Biocon, the Bangalore-based Company and Asia\’s largest insulin maker on Galvus or Vildagliptin, a DPP4 inhibitor class of drugs used to treat type-2 diabetes. Novartis filed the case on 27 …

Patent suit against Biocon- Keeping Galvus in check… Read More »

Patent Litigation Jackpot:

Marvell Technology Group Limited, the leading producer of Storage, communication products is entangled in a major patent Litigation case against a private Research University, Carnegie Mellon University (CMU). The federal court ordered Marvell to pay $1.5 Billion as enhanced penalties for deliberately infringing Carnegie’s Intellectual Property, the third largest ever in a patent case at …

Patent Litigation Jackpot: Read More »